Health-related quality of life and survival in the 2 years after surgery for gastric cancer

European Journal of Surgical Oncology

Volumn 36, Issue 2, 2010, Pages 148-154

  Avery, K ^a   Hughes, R ^a   McNair, A ^a,b   Alderson, D ^c   Barham, P ^b   Blazeby, J ^a,b,c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^c BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Decision making; Gastrectomy; Informed consent; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CANCER SURGERY; CANCER SURVIVAL; COGNITION; CONTROLLED STUDY; DECISION MAKING; DEMOGRAPHY; EMOTION; FEMALE; FUNCTIONAL ASSESSMENT; GASTRECTOMY; HEALTH SURVEY; HUMAN; INFORMED CONSENT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT INFORMATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; STOMACH CANCER; SURVIVAL TIME; TREATMENT OUTCOME;

ACTIVITIES OF DAILY LIVING; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; FEMALE; HEALTH STATUS; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 74149087808     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.09.008     Document Type: Article

References (25)

1. Pisani P., Parkin D.M., Bray F., and Ferlay J. Estimates of the worldwide mortality from 25 cancers in 1990. Int J Cancer 83 (1999) 18-29
2. Cunningham D., Allum W.H., Stenning S.P., et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 355 (2006) 11-20
3. Macdonald J.S., Smalley S.R., Benedetti J., et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med 345 (2001) 725-730
4. Sakuramoto S., Sasako M., Yamaguchi T., et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357 (2007) 1810-1820
5. Blazeby J.M., Avery K., Sprangers M., Pikhart H., Fayers P., and Donovan J. Health-related quality of life measurement in randomized clinical trials in surgical oncology. J Clin Oncol 24 (2006) 3178-3186
6. Medical Defence Union. Consent to treatment. Available from URL. http://www.the-mdu.com/associatedArticles/consent.pdf [accessed May 30, 2008]
7. General Medical Council. Seeking patients' consent: the ethical considerations. Available from URL. http://www.gmc-uk.org/guidance/current/library/consent.asp [accessed May 30, 2008]
8. Aaronson N., Ahmedzai S., Bergman B., et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85 (1993) 365-376
9. Vickery C., Blazeby J., Conroy T., et al. Development of an EORTC specific quality of life module for use in patients with gastric cancer. Eur J Cancer 37 (2001) 966-971
10. Blazeby J.M., Conroy T., Bottomley A., et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40 (2004) 2260-2268
11. Fayers P, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A. EORTC QLQ-C30 Scoring Manual. 3rd, 0-86; 2001.
12. Osoba D., Rodrigues G., Myles J., Zee B., and Pater J. Interpreting the significance of changes in health-related quality of life scores. J Clin Oncol 16 (1998) 139-144
13. Blazeby J.M., Sanford E., Falk S.J., Alderson D., and Donovan J.L. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer (2005) 1791-1799
14. Reynolds J.V., McLaughlin R., Moore J., Rowley S., Ravi N., and Byrne P.J. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg 93 (2006) 1084-1090
15. Cunningham D. STO3 a randomised phase II/III trial of peri-operative chemotherapy with or without bevacizumab in operable adenocarcinoma of the stomach and gastro-oesophageal junction. Medical Research Council Clinical Trial; 2008.
16. Zieren H.U., Zippel K., Zieren J., and Muller J.M. Quality of life after surgical treatment of gastric carcinoma. Eur J Surg 164 (1998) 119-125
17. Wu C.W., Chiou J.M., Ko F.S., Lo S.S., Chen J.H., Lui W.Y., et al. Quality of life after curative gastrectomy for gastric cancer in a randomised controlled trial. Br J Cancer 98 1 (2008) 54-59
18. Blazeby J.M., Conroy T., Bottomley A., Vickery C., Arraras J., Sezer O., et al. Clinical and psychometric validation of a questionnaire module, the EORTC QLQ-STO 22, to assess quality of life in patients with gastric cancer. Eur J Cancer 40 15 (2004) 2260-2268
19. Rutten L.J., Arora N.K., Bakos A.D., Aziz N., and Rowland J. Information needs and sources of information among cancer patients: a systematic review of research. Patient Educ Couns 2005 57 (1980-2003) 250-261
20. Skene L., and Smallwood R. Informed consent: lessons from Australia. BMJ 324 (2002) 39-41
21. General Medical Council. Consent: patients and doctors making decisions together; 2008.
22. Faden R.R., Beauchamp T.L., and King N.M. Understanding. A history and theory of informed consent (1986), Oxford University Press, New York
23. Brundage M., Feldman-Stewart D., Leis A., et al. Communicating quality of life information to cancer patients: a study of six presentation formats. J Clin Oncol 23 28 (2005) 6949-6956
24. Sobin L.H., and Ch W. Oesophagus (ICD-O C15). In: Sobin L.H., and Ch W. (Eds). TNM classification of malignant tumours. 6th ed (2002), A John Wiley & Sons, Inc, New York 60-69
25. Kim Y.W., Baik Y.H., Yun Y.H., et al. Improved quality of life outcomes after laparoscopy-assisted distal gastrectomy for early gastric cancer: results of a prospective randomized clinical trial. Ann Surg 248 5 (2008) 721-727